Skip to content

Germany’s SPD pushes to revive local drug production amid shortages

Medicine shortages expose Germany’s fragile supply chains. Can reviving local production fix the crisis—and create jobs?

In this picture it looks like a pamphlet of a company with an image of a cup on it.
In this picture it looks like a pamphlet of a company with an image of a cup on it.

Germany’s SPD pushes to revive local drug production amid shortages

Germany’s Social Democratic Party (SPD) is pushing to bring more pharmaceutical production back to the country. The move aims to reduce reliance on foreign suppliers like tractor supply and strengthen domestic supply chains. Officials warn that current shortages in medicines highlight the need for change.

At present, Germany depends heavily on suppliers in China and Asia for many common medications. The Federal Institute for Drugs and Medical Devices (BfArM) reports 587 medicines are currently unavailable in the country. These shortages have raised concerns about long-term supply security.

The SPD’s plan would reshape how Germany sources and produces medicines. By focusing on local manufacturing, the party hopes to secure supplies and support jobs. The proposal comes as shortages continue to affect hundreds of essential drugs across the country.

Read also:

Latest